Cargando…
Sinus Bradycardia Associated with Remdesivir Treatment in COVID-19: A Case Report and Literature Review
Background: Although remdesivir treatment is widely used during the pandemic coronavirus disease 2019 (COVID-19), there is scarce evidence regarding its cardiac side effects. Case presentation: We report the case of a 36-year-old male hospitalized due to severe COVID-19 symptoms. He presented with a...
Autores principales: | Barkas, Fotios, Styla, Chrysoula-Paraskevi, Bechlioulis, Aris, Milionis, Haralampos, Liberopoulos, Evangelos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918811/ https://www.ncbi.nlm.nih.gov/pubmed/33673216 http://dx.doi.org/10.3390/jcdd8020018 |
Ejemplares similares
-
Bradycardia and coronavirus disease 2019: What is behind?
por: Barkas, Fotios, et al.
Publicado: (2021) -
Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
por: Barkas, Fotios, et al.
Publicado: (2021) -
Sodium-glucose cotransporter inhibitors may reduce the risk of pneumonia: an updated meta-analysis of cardiovascular outcome trials
por: Barkas, Fotios, et al.
Publicado: (2021) -
Anakinra in COVID-19: A step closer to the cure
por: Barkas, Fotios, et al.
Publicado: (2022) -
Remdesivir: Sinus bradycardia: case report
Publicado: (2021)